Chronic type II interferon promotes tumor growth through mitochondrial RNA–induced type I interferon and prostaglandin synthesis
A new pathway shows chronic type II interferon can fuel tumors via mitochondrial RNA‑driven inflammation.
3 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 3 separate news trends connected to Tumor Growth, spanning July 16, 2026 through September 11, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 24 article observations and 24 source signals, led by Health coverage. Use it to compare how individual events emerged, spread and changed over time.
A new pathway shows chronic type II interferon can fuel tumors via mitochondrial RNA‑driven inflammation.
A newly developed covalent PFKL activator forces cancer cells to consume excess sugar, effectively stuntng tumor growth through metabolic overload.
A new study suggests that the ketogenic diet may promote cancer growth in the small intestine.